The store will not work correctly when cookies are disabled.
5-(2-amino-5-(methylcarbamoyl)oxazol-4-yl)furan-2-ylphosphonic acid
ID: ALA3218208
PubChem CID: 90665555
Max Phase: Preclinical
Molecular Formula: C9H10N3O6P
Molecular Weight: 287.17
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CNC(=O)c1oc(N)nc1-c1ccc(P(=O)(O)O)o1
Standard InChI: InChI=1S/C9H10N3O6P/c1-11-8(13)7-6(12-9(10)18-7)4-2-3-5(17-4)19(14,15)16/h2-3H,1H3,(H2,10,12)(H,11,13)(H2,14,15,16)
Standard InChI Key: JBTIPCKQKYSTJH-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
7.4537 -5.3696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2709 -5.3696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5253 -4.5928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8623 -4.1107 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2036 -4.5928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3028 -4.3414 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
9.9094 -4.8890 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.8901 -3.6278 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.8806 -3.7558 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.4263 -4.3407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1720 -3.5666 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3539 -3.5668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1026 -4.3456 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.7663 -4.8240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8728 -2.9062 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7698 -5.6446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0636 -6.0559 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4790 -6.0506 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.0667 -6.8731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 1 2 0
3 6 1 0
6 7 2 0
6 8 1 0
6 9 1 0
5 10 1 0
11 12 2 0
10 11 1 0
12 13 1 0
13 14 1 0
14 10 2 0
12 15 1 0
16 17 1 0
16 18 2 0
14 16 1 0
17 19 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 287.17 | Molecular Weight (Monoisotopic): 287.0307 | AlogP: -0.32 | #Rotatable Bonds: 3 |
Polar Surface Area: 151.82 | Molecular Species: ACID | HBA: 6 | HBD: 4 |
#RO5 Violations: ┄ | HBA (Lipinski): 9 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 1.23 | CX Basic pKa: ┄ | CX LogP: -2.08 | CX LogD: -5.17 |
Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.56 | Np Likeness Score: -0.34 |
References
1. Dang Q, Kasibthatla SR, Jiang T, Taplin F, Gibson T, Potter SC, van Poelje PD, Erion MD. (2011) Oxazole phosphonic acids as fructose 1,6-bisphosphatase inhibitors with potent glucose-lowering activity, 2 (4): [10.1039/C0MD00269K] |